Abaxis Inc (ABAX) Return on Assets ROA from the fourth quarter of 2018 to fourth quarter of 2017 and for the year 2018, Average High and Low, Fundamental Ratios from Mar 31 2018 to Mar 31 2017 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abaxis Inc  (ABAX)


Abaxis Inc's ROA from the fourth quarter of 2018 to the fourth quarter of 2017 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Abaxis Inc's ROA in the fourth quarter of 2018?
Abaxis Inc achieved a return on average assets (ROA) of 8.47 % in its fourth quarter of 2018, which is below Abaxis Inc's average return on assets, which stands at 10.38%.

ROA has improved compared to 8.07% in the third quarter of 2018, due to net income growth.

However, within the Healthcare sector 96 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2018 quarter, so far to 888, from total ROA ranking in the third quarter of 2018 at 962.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2018)
IV. Quarter		 (Dec 31 2017)
III. Quarter		 (Sep 30 2017)
II. Quarter		 (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
IV. Quarter
Y / Y Total Assets Change 11.6 % 12.09 % 10.92 % -3.48 % 12.63 %
Y / Y Net Income Change 25.91 % -38.25 % -42.26 % -8.13 % -14.8 %
Net Income (TTM) in million 27 25 27 32 33
Return On Assets (TTM) 8.47 % 8.07 % 9.2 % 11.12 % 11.22 %
ABAX's Total Ranking # 888 # 962 # 711 # 553 # 511
Total Assets (TTM) in million 341 330 320 269 306
Seq. Total Assets Change 3.51 % 3 % 18.96 % -12.01 % 3.96 %
Seq. Net Income Change 124.94 % -35.98 % 4.28 % -16.16 % 10.32 %

ABAX's 5 Years Annual ROA >> Back to ABAX Management Effectiveness >> Compare ABAX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 4
Sector # 97
Overall # 826

Return On Assets Statistics
High Average Low
13.82 %
10.38 %
6.76 %
  (Mar 31 2014)





Financial Statements
Abaxis Inc's Assets $ 341 million ABAX's Balance sheet
Abaxis Inc's Income $ 10 million Quarterly ABAX's Income Statement
ABAX's Income by Division See ABAX's Income by Division



Annual Return On Assets (Mar 31 2018)
FY 2018		 (Mar 31 2017)
FY 2017		 (Mar 31 2016)
FY 2016		 (Mar 31 2015)
FY 2015		 (Mar 31 2014)
FY 2014
Y / Y Total Assets Change 11.6 % 12.63 % 0.86 % 24 % 7.54 %
Total Assets in million 341 306 271 269 217
Y / Y Net Income Change -16.93 % 3.43 % 15.73 % 92.68 % -48.34 %
Net Income in million 27 33 32 27 14
Annual Return On Assets 7.97 % 10.7 % 11.66 % 10.16 % 6.54 %

ABAX's 5 Years Annual ROA >> Back to ABAX Management Effectiveness >> Compare ABAX ROA to its Competitors



Comment on ABAX's ROA in the fiscal year ending 2018
In the fiscal year 2018 Abaxis Inc's ROA decreased compared to previous year to 7.97 %, due to deterioration of net income -16.93 % to $27.18 million, from $32.72 million a year ago, as ABAX's assets were $341.10 million.


More Return On Assets Ratios
ABAX's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ABAX's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ABAX's Competitors
Subscribers only: Roa for Abaxis Inc's Suppliers
Subscribers only: Return On Assets for ABAX's Customers

You may also want to know
ABAX's Roi ABAX's Inventory Turnover Ratio ABAX's Growth Rates ABAX's Dividend Comparisons
ABAX's Profitability Ratios ABAX's Asset Turnover Ratio ABAX's Dividend Growth
ABAX's Roe ABAX's Valuation Ratios ABAX's Financial Strength Ratios ABAX's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2018, within Healthcare Sector ROA
Psychemedics Corporation  22.73 %
Regenxbio Inc   22.35 %
Ligand Pharmaceuticals Incorporated  21.01 %
Fonar Corporation  20.76 %
Nrc Health  18.55 %
Idexx Laboratories Inc  17.49 %
Atrion Corporation  17.33 %
Alpha Pro Tech Ltd   17.25 %
United Therapeutics Corporation  16.79 %
Regeneron Pharmaceuticals Inc   16.34 %
Enanta Pharmaceuticals Inc  16.31 %
Plx Pharma Inc   16.23 %
Bio rad Laboratories Inc   16.18 %
Jrsis Health Care Corp  16.16 %
Halozyme Therapeutics Inc   15.93 %
Pacific Health Care Organization Inc  15.84 %
Biospecifics Technologies Corp  15.74 %
Capricor Therapeutics inc   15.74 %
Abiomed Inc   15.73 %
Mettler toledo International Inc   15.37 %
Align Technology inc   15.15 %
Supernus Pharmaceuticals inc   14.80 %
Pfizer Inc  14.69 %
Cambrex Corp  14.67 %
Lemaitre Vascular Inc   14.57 %
Intuitive Surgical Inc   13.43 %
Biogen Inc   13.09 %
Masimo Corp  12.99 %
Carlisle Companies Incorporated  12.68 %
Chemed Corporation  12.46 %

Date modified: 2026-07-06T17:55:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.